With the number of COVID-19 cases rising, the country might need anywhere between 1,10,000 and 2,20,000 ventilators by May 15 in the worst-case scenario, according to an analysis by think tank Brookings India.
It is crucial to move beyond RT-PCR tests because they would have “very little value” in the event people with positive antibodies to the virus (meaning they have COVID-19 but their immune system has tackled the virus) are tested, according to her.
While some authorities including Delhi Police, Gurugram Police, Noida Police and Ahmedabad Municipal Corporation instituted mechanisms for allowing home deliveries, many raised concerns over non-adherence of Union Ministry of Home Affairs orders in different states.
India’s response system is not watertight, leaving the possibility for community transmission cases, according to Dr Gagandeep Kang, executive director of Translational Health Science and Technology Institute, an autonomous body under the Science and Technology Ministry’s Department of Biotechnology.
Diagnosing COVID-19 for free without such relaxations may not be a viable model for these firms, as they will have to bear logistics, manpower and testing costs on their own, according to some representatives of private labs.
NPPA on Thursday evening also stated in a tweet that it has asked the Himachal Pradesh drug controller to “take notice” of reported problems faced by pharmaceutical companies in Baddi and “act immediately to ensure uninterrupted availability of APIs.”
The development comes after an earlier exercise by the council to zero in on alternatives that could keep the country from running out of crucial stocks of various painkillers, antibiotics, antidiabetic and cardiovascular medicines as well as vitamins, The Indian Express has learnt.
GoI has also decided to suspend with immediate effect all regular visas and e-visas issued to nationals of Italy, Iran, South Korea and Japan issued on or before March 3 and have not entered India yet.